SYN2

Across TCGA pan-cancer cohorts, SYN2 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SYN2 data layer compared with 25 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SYN2 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated SYN2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CCRCC show a favorable association.

HNSC, LUAD, and CCRCC are the cancer types where SYN2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	0.920	0.531	.002	13	view →
LUAD	DFS	Tertile	All	0.773	1.000	.010	8	view →
CCRCC	DFS	Quartile	All	0.904	0.516	.032	5	view →
GBM	DFS	Tertile	All	0.799	0.626	.043	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SYN2–HNSC (OS)

Open the HNSC breakdown →